These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 9137841

  • 1. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
    Ramadan NM, Schultz LL, Gilkey SJ.
    Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
    [Abstract] [Full Text] [Related]

  • 2. Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
    Yaldo AZ, Wertz DA, Rupnow MF, Quimbo RM.
    Clin Ther; 2008 Dec; 30(12):2452-60. PubMed ID: 19167603
    [Abstract] [Full Text] [Related]

  • 3. Drugs for preventing migraine headaches in children.
    Victor S, Ryan SW.
    Cochrane Database Syst Rev; 2003 Dec; (4):CD002761. PubMed ID: 14583952
    [Abstract] [Full Text] [Related]

  • 4. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A, Song D, Zhang L, Li C.
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [Abstract] [Full Text] [Related]

  • 5. Canadian Headache Society guideline for migraine prophylaxis.
    Pringsheim T, Davenport W, Mackie G, Worthington I, Aubé M, Christie SN, Gladstone J, Becker WJ, Canadian Headache Society Prophylactic Guidelines Development Group.
    Can J Neurol Sci; 2012 Mar; 39(2 Suppl 2):S1-59. PubMed ID: 22683887
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J.
    Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence based migraine prophylactic drug therapy.
    Becker WJ.
    Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S27-32. PubMed ID: 10563230
    [Abstract] [Full Text] [Related]

  • 14. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
    Goncalves DA, Camparis CM, Speciali JG, Castanharo SM, Ujikawa LT, Lipton RB, Bigal ME.
    J Orofac Pain; 2013 Nov; 27(4):325-35. PubMed ID: 24171182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Migraine prophylaxis. A comparison of propranolol and amitriptyline.
    Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskorn SH, Mason J.
    Arch Neurol; 1987 May; 44(5):486-9. PubMed ID: 3579659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Propranolol for migraine prophylaxis.
    Linde K, Rossnagel K.
    Cochrane Database Syst Rev; 2004 May; (2):CD003225. PubMed ID: 15106196
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.